Mental Health
Optimizing Depression Management in Pharmacy Practice
Depression (MDD*) can significantly affect an individual’s health, leading to social and occupational impairment, diminished self-management of comorbidities, diminished quality of life, and an elevated risk of death by suicide. This program supports clinicians in effectively identifying and managing depression in their patients.
The program will review the signs and symptoms of depression and discuss a range of treatment options, including both pharmacological and non-pharmacological approaches.
By the end of the session, clinicians will be better prepared to deliver comprehensive and effective care to patients with depression.
*Major Depressive Disorder
DURATION
30 min
PROFESSION
Pharmacy
# OF CREDITS
0.75
ACCREDITATION
CCCEP, OPQ
EXPIRY DATE
2025-10-03
Depression (MDD*) can significantly affect an individual’s health, leading to social and occupational impairment, diminished self-management of comorbidities, diminished quality of life, and an elevated risk of death by suicide. This program supports clinicians in effectively identifying and managing depression in their patients.
The program will review the signs and symptoms of depression, discuss a range of treatment options, including both pharmacological and non-pharmacological approaches. By the end of the session, clinicians will be better prepared to deliver comprehensive and effective care to patients with depression.
* Major Depressive Disorder
Faculty
Daniel Mueller, MD, PhD
Chandi Chandrasena, MD, CCFP, FCFP
Javed Alloo, MD, CCFP, MPLc
Jeff Habert, MD, CCFP, FCFP
Betty Golightly, B.Sc. (Pharm), RPh
John Papastergiou, BSc, BScPhm, PhD, RPh
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Describe the common signs and symptoms of MDD
- Compare the different antidepressant classes and adjunctive therapies by their role in therapy, tolerability, and efficacy
- Discuss approaches and tools to achieve symptom remission
- Review non-pharmacological treatment options and their role in therapy
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.75 CEU(s).
CCCEP File Number: 1066-2024-3851-I-P
This continuing educational activity has been accredited by the OPQ; 0.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program.
Accreditation number: 240128
#
of credits: 0.75
Duration: 30 min
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
30 min
Duration
Pharmacy
Profession
0.75
# of credits
Learning Objectives
Upon completion of this continuing education program participants will be better able to:
- Describe the common signs and symptoms of MDD
- Compare the different antidepressant classes and adjunctive therapies by their role in therapy, tolerability, and efficacy
- Discuss approaches and tools to achieve symptom remission
- Review non-pharmacological treatment options and their role in therapy
CCCEP
Accredited
Course
CCCEP, OPQ
ACCREDITATION
Mental Health
Learning Category
Depression, Major Depressive Disorder
Topic
0
Price
2025-10-03
Expiry Date
CAN-eng
Region/Language
Course Description
Depression (MDD*) can significantly affect an individual’s health, leading to social and occupational impairment, diminished self-management of comorbidities, diminished quality of life, and an elevated risk of death by suicide. This program supports clinicians in effectively identifying and managing depression in their patients.
The program will review the signs and symptoms of depression, discuss a range of treatment options, including both pharmacological and non-pharmacological approaches. By the end of the session, clinicians will be better prepared to deliver comprehensive and effective care to patients with depression.
* Major Depressive Disorder
Faculty
Daniel Mueller, MD, PhD
Chandi Chandrasena, MD, CCFP, FCFP
Javed Alloo, MD, CCFP, MPLc
Jeff Habert, MD, CCFP, FCFP
Betty Golightly, B.Sc. (Pharm), RPh
John Papastergiou, BSc, BScPhm, PhD, RPh
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.75 CEU(s).
CCCEP File Number: 1066-2024-3851-I-P
This continuing educational activity has been accredited by the OPQ; 0.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program.
Accreditation number: 240128
30 min
Duration
0
Price
0.75
# of credits
